Getinge bids up to $290m to buy High Purity New England

Getinge strengthens its presence in the bioprocessing solutions market with the acquisition of HPNE.

Kiays Khalil June 01 2023

Swedish company Getinge has announced plans to take over High Purity New England (HPNE) in a deal worth up to $290 million.

HPNE supplies products that help biopharmaceutical and biotechnology players in the production of monoclonal antibodies, vaccines, cell and gene therapies and other next-generation therapies. The range of products include drug discovery and upstream and downstream processing.

Getinge’s latest buy will grow its presence in the bioprocessing space in a deal that is expected to close in Q3 2023. According to the terms of the deal, the company will pay SEK 1,300 million ($120 million) in cash to take over all remaining shares from HPNE. An additional SEK 1,850 M ($170 million) can be paid out in 2024 - 2026 if agreed net revenue performance milestones are achieved in 2023 - 2025.

The acquisition is not expected to impact Getinge’s operating profit and earnings per share in 2023.

“This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment,” said Eric Honroth, President of Life Science at Getinge.

Over the years HPNE has supplied the industry with single use assemblies and earlier this year launched FlexxConnexx, a service for single use assembly that reduces lead times and creates security in the SU supply chain.

The planned purchase of 100% of HPNE shares follows a recent acquistion of Ultra Clean Systems and its ultrasonic cleaning tech for SEK 170 million ($16 million). In April Getinge partnered with the Indian Institute of Technology (IIT) focusing on the use of artificial intelligence (AI) to help understaffed intensive care units detect which patients need urgent care.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

No previous editions found

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close